| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/14/2011 | CN102186491A Hig2 and urlc10 epitope peptide and vaccines containing the same |
| 09/14/2011 | CN102183655A New molecular marker CUEDC2 (CUE Domain Containing 2) protein for prognosis judgement in endocrine therapy of breast cancer |
| 09/14/2011 | CN102181461A Method for expressing target polypeptide on filobactivirus at high density and application thereof |
| 09/14/2011 | CN102181457A Clostridium difficile exotoxin B amino-terminal gene sequence with optimized codon and nucleic vaccine of clostridium difficile exotoxin B |
| 09/14/2011 | CN102181450A Trichina Ts27 gene, encoding protein and application thereof |
| 09/14/2011 | CN102181426A Expression and application of human papilloma virus type16 and 18 L1 protein in yeast |
| 09/14/2011 | CN102181408A Preparation method and application of Saint Louis encephalitis virus-like particles |
| 09/14/2011 | CN102181400A Hybridoma cell strain and anti-HCCLM-6 (Human Hepatoma Cell Line) cell secretory protein monoclonal antibody |
| 09/14/2011 | CN102180974A Tubercle bacillus fusion protein and preparation method and application thereof |
| 09/14/2011 | CN102180971A Recombinant beta-amyloid peptide B cell epitope polypeptide chimeric antigen and preparation method and application thereof |
| 09/14/2011 | CN102180969A Monoclonal antibody with liver cancer resisting activity and application thereof |
| 09/14/2011 | CN102180962A Tetraodon nigroviridis interferon IFNgamma1 and preparation method and application thereof |
| 09/14/2011 | CN102180961A Black-blue spotted puffer fish interferon IFN gamma 2 and preparation method and application thereof |
| 09/14/2011 | CN102180952A Foot and mouth disease virus antigen polypeptide, fusion antigen polypeptide and vaccine |
| 09/14/2011 | CN102180951A Cholesterol modified anti-human immunodeficiency virus (HIV) polypeptide medicament and application thereof |
| 09/14/2011 | CN102180950A Human-derived voltage-gated potassium channel 1.3 immunogenic peptide fragment and application thereof |
| 09/14/2011 | CN102180944A Remodeling and glycoconjugation of peptides |
| 09/14/2011 | CN102178958A MBD2-mTEM fused DNA vaccine and preparation method and application thereof |
| 09/14/2011 | CN102178955A Idiotoxin solvent and preparation method thereof |
| 09/14/2011 | CN102178953A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 09/14/2011 | CN102178952A Method for extracting human TIG (Tetanus Immune Globulin) based on chromatography |
| 09/14/2011 | CN102178951A Method for producing intravenous injection human immune globulin |
| 09/14/2011 | CN102178950A Subunit vaccine immunologic adjuvant and application thereof |
| 09/14/2011 | CN102178949A Combined vaccine for adsorbing Diphtheria, tetanus and acellular pertussis-Sabin inactivated poliovirus and preparation thereof |
| 09/14/2011 | CN102178948A Genetic engineering drug for treating and/or preventing cervical cancer |
| 09/14/2011 | CN102178947A Live vector vaccine for expressing peste des petits ruminants virus (PPRV) H gene and preparation method thereof |
| 09/14/2011 | CN102178946A Application of baby hamster kidney(BHK)-21 cell serum-free suspension culture technology in foot-and-mouth disease vaccine production |
| 09/14/2011 | CN102178945A Preparation method of inactivated vaccine for iridovirus of grouper |
| 09/14/2011 | CN102178944A Expression and application of human papilloma viruses type 16 and 18 L1 proteins in inset cells |
| 09/14/2011 | CN102178943A Cross protection vaccine |
| 09/14/2011 | CN102178942A High-efficiency non-injection type transmission method for live vaccine |
| 09/14/2011 | CN102178941A Novel helicobacter pylori multiepitope vaccine and preparation method thereof |
| 09/14/2011 | CN102178940A Cancertestis antigen HCA587 protein vaccine and application thereof |
| 09/14/2011 | CN102178686A Medicament and vaccine for polysaccharide-related disease and immunoassay product |
| 09/14/2011 | CN102178655A Osteocalcin (OC) freeze-dried powder preparation for injection |
| 09/14/2011 | CN101837134B Chronic myeloid leukemia DNA vaccine BCR/ABL-pIRES-SEA and preparation method and application thereof |
| 09/14/2011 | CN101612397B Duck virus hepatitis inactivated vaccine and preparation method thereof |
| 09/14/2011 | CN101580546B Human anti human interferon alpha antibody and application thereof |
| 09/14/2011 | CN101550182B Swine hepatitis E virus epitope and application thereof |
| 09/14/2011 | CN101463085B Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
| 09/13/2011 | US8017754 Attenuated virus strains and uses thereof |
| 09/13/2011 | US8017753 Mycobacterial antigens expressed under low oxygen tension |
| 09/13/2011 | US8017749 Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
| 09/13/2011 | US8017745 Plasmodium falciparum antigens and methods of use |
| 09/13/2011 | US8017735 Comprising one or more binding compositions comprising a member selected from a light chain amino acid sequence which comprises CDR-L1 and a heavy chain amino acid sequence which comprises CDR-H1 in association with one or more chemotherapeutic agents; cancer therapy |
| 09/13/2011 | US8017733 Covalent attachment of hydrophilic polymers, such as polyalkylene glycol polymers, also known as polyalkylene oxides, to biologically-active molecules |
| 09/13/2011 | US8017731 Hemopoietic receptor protein, NR10 |
| 09/13/2011 | US8017725 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/13/2011 | US8017591 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals |
| 09/13/2011 | US8017590 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/13/2011 | US8017584 Tumor associated antigens; fusion proteins; antibodies; keyhole limpet hemocyanin carrier enhances immunogenicity |
| 09/13/2011 | US8017388 Tumour cell lines and uses thereof |
| 09/13/2011 | US8017344 Methods for detecting Th1 cells |
| 09/13/2011 | US8017343 Cytokine zalpha11 ligand antibodies and methods of use |
| 09/13/2011 | US8017317 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 09/13/2011 | US8017154 Polyamino acid for use as adjuvant |
| 09/13/2011 | US8017134 Recombinant toxin fragments |
| 09/13/2011 | US8017133 Multicomponent vaccines |
| 09/13/2011 | US8017132 Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell |
| 09/13/2011 | US8017131 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 09/13/2011 | US8017130 Method of accelerated vaccination against Ebola viruses |
| 09/13/2011 | US8017129 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma |
| 09/13/2011 | US8017127 Influenza immunogen and vaccine |
| 09/13/2011 | US8017126 Modified HIV-1 envelope proteins |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | US8017124 Use of the human protein Deleted in Malignant Brain Tumors 1 in the diagnosis, prophylaxis or treatment of diseases caused by an agent that has at least one accessible sulfate and/or phosphate group, such as a microorganism; ulcerative colitis; cancer of respiratory system or alimentary tract |
| 09/13/2011 | US8017122 Methods of using IL-31 monoclonal antibodies to reduce inflammation |
| 09/13/2011 | US8017121 Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 09/13/2011 | US8017120 Method for inhibiting bone resorption |
| 09/13/2011 | US8017119 Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved |
| 09/13/2011 | US8017117 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/13/2011 | US8017116 Using growth factor specific immunoglobulin as therapeutic in treating eye tissue injury |
| 09/13/2011 | US8017115 Therapeutical use of anti-myelin associated glycoprotein (MAG) antibodies |
| 09/13/2011 | US8017114 Human CTLA-4 antibodies and their uses |
| 09/13/2011 | US8017113 Compositions and methods for diagnosing and treating an inflammation |
| 09/13/2011 | US8017103 Methods and compositions to diagnose trichomonas infection |
| 09/13/2011 | CA2640663C Intranasal delivery system |
| 09/13/2011 | CA2568352C Methods of using il-1 antagonists to treat autoinflammatory disease |
| 09/13/2011 | CA2480276C Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 09/13/2011 | CA2465303C Compositions and methods for wt1 specific immunotherapy |
| 09/13/2011 | CA2356836C Novel streptococcus antigens |
| 09/13/2011 | CA2327587C Methods for treatment of haemophilia a patients using human anti-human fviii antibodies |
| 09/13/2011 | CA2297101C Receptor specific transepithelial transport of therapeutics |
| 09/13/2011 | CA2224127C Flagellin gene, flac of campylobacter |
| 09/13/2011 | CA2220964C Alphavirus rna replicon systems |
| 09/13/2011 | CA2187535C Borrelia burgdorferi bacterin |
| 09/09/2011 | WO2011109663A1 Neoplasia-specific autoantibodies and methods |
| 09/09/2011 | WO2011109662A1 Monoclonal antibodies directed to cd52 |
| 09/09/2011 | WO2011109452A1 Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) |
| 09/09/2011 | WO2011109400A2 Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| 09/09/2011 | WO2011109338A1 Methods and compositions for treating degos' disease |
| 09/09/2011 | WO2011109308A1 Methods for screening antibodies |
| 09/09/2011 | WO2011109298A2 Therapeutic dll4 binding proteins |
| 09/09/2011 | WO2011109280A1 Methods and compositions to treat immune-mediated disorders |
| 09/09/2011 | WO2011109108A1 Monoclonal antibodies directed to cd20 |
| 09/09/2011 | WO2011108999A1 Vaccines and vaccine compositions, and methods for the manufacture thereof |
| 09/09/2011 | WO2011108937A1 B-cell stimulating fusion proteins of an antigen with baff or april |
| 09/09/2011 | WO2011108785A1 Peptide compound having inhibitory activity for infection or proliferation of orientia tsutsugamushi, and pharmaceutical composition for relieving scrub typhus using same |
| 09/09/2011 | WO2011108714A1 Antibody constant region variant |
| 09/09/2011 | WO2011108638A1 Drug for inflammatory bowel disease |